423 results found

The EU continues its ambitious reform agenda for life sciences regulation, with landmark agreements on pharmaceutical legislation and biotech innovation frameworks. Ireland's Council Presidency is set to drive progress on critical medicines legislation and medical device reforms, while new investment initiatives aim to mobilize billions into Europe's biotech sector.

Michael Egan and Michael Scorer explore how organisations are transitioning from AI experimentation to practical implementation in legal workflows. They examine why generative AI adoption has doubled while confidence remains low, and discuss the critical role of defensibility, governance, and human oversight in successful AI deployment.

One of the key provisions of the UCITS IV Directive, which was approved by the European Commission on 13 January 2009, is the implementation of the key investor information document ("KIID"). This document replaces the simplified prospectus which was required pursuant to the UCITS III Directive and which was seen to have a number of shortcomings.

On 20th February 2016 David Cameron announced that Britain would, on 23rd June 2016, hold a referendum on the United Kingdom's membership of the European Union.

The Irish Government has published the Regulation of Artificial Intelligence Bill 2026, establishing a comprehensive framework for supervising and enforcing the EU AI Act in Ireland. This legislation creates the AI Office of Ireland as an independent statutory body to coordinate AI regulation, introduces a distributed oversight model involving multiple sectoral authorities, and provides detailed procedures for adjudication and administrative sanctions. The Bill addresses critical questions about how Ireland

On 2 June 2016 the Central Bank published an updated UCITS Q&A document (the "Q&A"), setting out answers to queries likely to arise in relation to UCITS.

Legal measures are now in place for corporate investment funds to re-domicile to Ireland. This paper considers some of the more practical questions facing asset managers considering re-domiciling funds to Ireland under the new regime and provides a guide as to how the process shall work in practice.

On 3 February 2026, European Insurance and Occupational Pensions Authority ("EIOPA") launched a public consultation (the "Consultation") on the supervisory statement on the authorisation and ongoing supervision of (re)insurance undertakings related to private equity ("PE") firms (the "Supervisory Statement").

On 26 September 2023, the Government Legislation ProgrammeOpens in new window ("Programme") for Autumn 2023 was published. The Programme identifies 27...

Over the last 25 years, Ireland has earned a reputation as a leading domicile for internationally focussed regulated investment funds.

Council of the European Union publishes texts of proposed Directive and Regulation to improve MiFID II market data access and transparency...

On 30 September 2015, the European Commission adopted a Delegated Regulation amending the Solvency II Delegated Regulation concerning the calculation of regulatory capital requirements...